Mounjaro launches early in Brazil; prices revealed

odia.ig.com.br (Portuguese)

Eli Lilly has announced the early arrival of Mounjaro (tirzepatide) in Brazil, with availability expected by May 15th. The medication is for treating type 2 diabetes. Initially, only 2.5mg and 5mg pen dosages will be available, with prices ranging from R$1,406.75 to R$2,384.34 for a month's supply. The company is awaiting approval for obesity treatment. Mounjaro, a dual agonist, works by mimicking GLP-1 and GIP hormones. It is administered weekly via injection and has shown greater effectiveness than Ozempic in studies.


With a significance score of 4, this news ranks in the top 5.4% of today's 30691 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers: